Medherant Limited

POWER SEARCH PRICING

SOLUTIONS

medherant limited Company Information

Live

EstablishedSmallRapid

Company Number

08973262

Next Accounts

Dec 2025

Industry

Research and experimental development on biotechnology

Directors

David Haddleton

Kenneth Cunningham

View All

Shareholders

james robson

mercia (general partner) ltd as general partner of mercia investment plan lp

View All

Group Structure

View All

Contact

Registered Address

the venture centre, sir william lyons road,, coventry, CV4 7EZ

Website

www.medherant.co.uk

medherant limited Estimated Valuation

£5.1m

Pomanda estimates the enterprise value of MEDHERANT LIMITED at £5.1m based on a Turnover of £3.2m and 1.58x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Medherant Limited is a live company located in coventry, CV4 7EZ with a Companies House number of 08973262. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2014, it's largest shareholder is james robson with a 74.7% stake. Medherant Limited is a established, small sized company, Pomanda has estimated its turnover at £3.2m with rapid growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Medherant Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

3 Strong

3 Regular

5 Weak

Size

annual sales of £3.2m, make it in line with the average company (£3.3m)

Growth

3 year (CAGR) sales growth of 36%, show it is growing at a faster rate (15%)

EXPORT

Medherant Limited's latest turnover from March 2024 is estimated at £3.2 million and the company has net assets of £417 thousand. According to their latest financial statements, Medherant Limited has 21 employees and maintains cash reserves of £706 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Turnover	3,240,629	1,313,808	1,161,074	1,277,908	1,563,469	1,589,869	883,387	889,964	403,602	2,325
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,399,894	606,137	594,646	618,537	765,289	772,633	400,871	435,491	211,946	1,216
Gross Profit	1,840,735	707,671	566,428	659,372	798,180	817,237	482,517	454,472	191,656	1,108
Admin Expenses	3,662,559	2,066,120	2,021,117	2,820,259	2,719,078	3,180,296	2,229,011	1,163,308	426,907	26,622
Operating Profit	-1,821,824	-1,358,449	-1,454,689	-2,160,887	-1,920,898	-2,363,059	-1,746,494	-708,836	-235,251	-25,514
Interest Payable	112,500	129,406	197,944	177,365	59,102	15,610	0	0	0	0
Interest Receivable	96,547	94,683	12,761	1,525	1,222	15,976	10,019	1,809	1,708	740
Pre-Tax Profit	-1,837,777	-1,393,172	-1,639,872	-2,336,727	-1,978,778	-2,362,693	-1,736,475	-707,027	-233,543	-24,774
Tax	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-1,837,777	-1,393,172	-1,639,872	-2,336,727	-1,978,778	-2,362,693	-1,736,475	-707,027	-233,543	-24,774
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Retained Profit	-1,837,777	-1,393,172	-1,639,872	-2,336,727	-1,978,778	-2,362,693	-1,736,475	-707,027	-233,543	-24,774
Employee Costs	1,712,415	1,239,085	1,316,685	1,212,652	1,325,932	1,358,263	914,695	519,269	215,736	52,845
Number Of Employees	21	17	18	18	20	21	15	9	4	1
EBITDA*	-1,754,823	-1,281,682	-1,351,102	-2,061,108	-1,826,842	-2,276,781	-1,702,045	-694,844	-229,745	-25,514

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Tangible Assets	98,400	113,444	138,789	177,535	186,086	228,524	278,336	83,452	42,611	967
Intangible Assets	366,693	217,410	192,540	289,395	194,427	137,600	63,891	37,525	8,780	0
Investments & Other	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	465,093	330,854	331,329	466,930	380,513	366,124	342,227	120,977	51,391	967
Stock & work in progress	0	0	0	0	0	0	0	0	0	797
Trade Debtors	744,397	108,501	55,200	86,791	0	0	20,000	0	0	0
Group Debtors	0	0	0	0	0	0	0	0	0	0
Misc Debtors	615,541	424,471	401,985	613,502	365,254	535,472	356,562	142,074	42,467	205
Cash	706,041	2,971,955	1,483,722	1,919,088	1,131,481	1,312,910	2,947,326	1,060,343	387,133	295,876
misc current assets	0	0	0	0	0	0	0	0	0	0
total current assets	2,065,979	3,504,927	1,940,907	2,619,381	1,496,735	1,848,382	3,323,888	1,202,417	429,600	296,878
total assets	2,531,072	3,835,781	2,272,236	3,086,311	1,877,248	2,214,506	3,666,115	1,323,394	480,991	297,845
Bank overdraft	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0
Trade Creditors	451,447	141,040	47,719	363,967	14,774	36,910	141,812	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0
other short term finances	1,000,000	1,000,000	1,525,003	1,540,003	1,475,255	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0
other current liabilities	662,658	439,997	514,632	562,821	230,996	544,584	31,749	58,735	33,789	20,017
total current liabilities	2,114,105	1,581,037	2,087,354	2,466,791	1,721,025	581,494	173,561	58,735	33,789	20,017
loans	0	0	0	2,800,000	0	462,508	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	2,800,000	0	462,508	0	0	0	0
total liabilities	2,114,105	1,581,037	2,087,354	5,266,791	1,721,025	1,044,002	173,561	58,735	33,789	20,017
net assets	416,967	2,254,744	184,882	-2,180,480	156,223	1,170,504	3,492,554	1,264,659	447,202	277,828
total shareholders funds	416,967	2,254,744	184,882	-2,180,480	156,223	1,170,504	3,492,554	1,264,659	447,202	277,828

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Operating Activities
Operating Profit	-1,821,824	-1,358,449	-1,454,689	-2,160,887	-1,920,898	-2,363,059	-1,746,494	-708,836	-235,251	-25,514
Depreciation	44,455	62,931	84,550	82,948	82,816	72,404	44,449	13,992	5,506	0
Amortisation	22,546	13,836	19,037	16,831	11,240	13,874	0	0	0	0
Tax	0	0	0	0	0	0	0	0	0	0
Stock	0	0	0	0	0	0	0	0	-797	797
Debtors	826,966	75,787	-243,108	335,039	-170,218	158,910	234,488	99,607	42,262	205
Creditors	310,407	93,321	-316,248	349,193	-22,136	-104,902	141,812	0	0	0
Accruals and Deferred Income	222,661	-74,635	-48,189	331,825	-313,588	512,835	-26,986	24,946	13,772	20,017
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-2,048,721	-1,338,783	-1,472,431	-1,715,129	-1,992,348	-2,027,758	-1,821,707	-769,505	-257,438	-6,499
Investing Activities
capital expenditure	-201,240	-76,292	32,014	-186,196	-108,445	-110,175	-265,699	-83,578	-55,930	-967
Change in Investments	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-201,240	-76,292	32,014	-186,196	-108,445	-110,175	-265,699	-83,578	-55,930	-967
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	-525,003	-15,000	64,748	1,475,255	0	0	0	0	0
Long term loans	0	0	-2,800,000	2,800,000	-462,508	462,508	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0
share issue	0	3,463,034	4,005,234	24	964,497	40,643	3,964,370	1,524,484	402,917	302,602
interest	-15,953	-34,723	-185,183	-175,840	-57,880	366	10,019	1,809	1,708	740
cash flow from financing	-15,953	2,903,308	1,005,051	2,688,932	1,919,364	503,517	3,974,389	1,526,293	404,625	303,342
cash and cash equivalents
cash	-2,265,914	1,488,233	-435,366	787,607	-181,429	-1,634,416	1,886,983	673,210	91,257	295,876
overdraft	0	0	0	0	0	0	0	0	0	0
change in cash	-2,265,914	1,488,233	-435,366	787,607	-181,429	-1,634,416	1,886,983	673,210	91,257	295,876

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for medherant limited. Get real-time insights into medherant limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for medherant limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CV4 area or any other competitors across 12 key performance metrics.

MEDHERANT LIMITED group structure

Medherant Limited has no subsidiary companies.

Ultimate parent company

MEDHERANT LIMITED

08973262

MEDHERANT LIMITED Shareholders

james robson	74.65%
mercia (general partner) ltd as general partner of mercia investment plan lp	10.18%
mnl (mercia) nominees limited	2.52%
andrew fisher	2.46%
uk ff nominees ltd	1.89%
david haddleton	1.8%
mercia fund 1 general partner limited as a. general partner of the mercia fund 1	1.55%
the university of warwick	1.54%
nigel theobald	0.5%
andrew haddleton	0.5%

Medherant Limited currently has 4 directors. The longest serving directors include Mr David Haddleton (Apr 2014) and Dr Kenneth Cunningham (Jan 2017).

officer	country	age	start	end	role
Mr David Haddleton	England	62 years	Apr 2014	-	Director
Dr Kenneth Cunningham	England	72 years	Jan 2017	-	Director
Dr William Burt	England	56 years	Jul 2019	-	Director
Dr Francesca Crawford	England	72 years	Jul 2023	-	Director

P&L

March 2024

turnover

3.2m

+147%

operating profit

-1.8m

gross margin

56.9%

+5.45%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

417k

-0.82%

total assets

2.5m

-0.34%

cash

706k

-0.76%

net assets

Total assets minus all liabilities

Similar Companies

maybrook developments (appley bridge) ltd

arden biotechnology limited

1.5

bionemax uk limited

mina therapeutics limited

soligenix uk limited

company number

08973262

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

April 2014

ultimate parent company

None

previous names

N/A

address

the venture centre, sir william lyons road,, coventry, CV4 7EZ

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to medherant limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEDHERANT LIMITED. This can take several minutes, an email will notify you when this has completed.

medherant limited Company Information

medherant limited Estimated Valuation

medherant limited Estimated Valuation

medherant limited Estimated Valuation

Medherant Limited Overview

Medherant Limited Health Check

MEDHERANT LIMITED financials

medherant limited Credit Report and Business Information

Medherant Limited Competitor Analysis

medherant limited Ownership

medherant limited directors

medherant limited company details

medherant limited Charges & Mortgages

medherant limited Capital Raised & Share Issues BETA

medherant limited Companies House Filings - See Documents